1. Seven-year overview of antimicrobial resistance in diarrheagenic Escherichia coli from sporadic human diarrhea cases in 20 Chinese provinces.
- Author
-
Han, Haihong, Li, Weiwei, Liu, Jikai, Zhang, Xiaoai, Huo, Xiang, Sun, Yong, Chen, Jiancai, Fan, Ruyue, Zhang, Jing, Chen, Yong, Yang, Hongxia, Chen, Shuai, Li, Yanfen, Tan, Dongmei, Ma, Xuemin, Fan, Penghui, Yan, Shaofei, and Guo, Yunchang
- Subjects
- *
ESCHERICHIA coli , *DIARRHEA , *FOODBORNE diseases , *MICROBIAL sensitivity tests - Abstract
Diarrheagenic Escherichia coli is one of the most prevalent foodborne pathogens and poses significant clinical challenges due to increasing rates of antibiotic resistance. In this study, 9,068 diarrheagenic E. coli isolates from sporadic diarrhea cases across 20 provinces of China from 2016 to 2022 were systematically analyzed to determine the prevalence and distribution of resistance. A total of 14 antibiotics were included in the antimicrobial resistance surveillance. Antimicrobial susceptibility testing indicated that the majority of the isolates (89.3%) were resistant to at least one antimicrobial agent, with a significant proportion (60.3%) demonstrating multidrug resistance. Isolates showed high levels of resistance to ampicillin (68.2%) and high sensitivity to imipenem (97.0%). Over the 7 years, an increasing trend in resistance to cefoxitin and chloramphenicol among the isolates was found. Enteroaggregative E. coli was identified as the predominant pathotype. Furthermore, antimicrobial resistance rates were higher among the isolates from infants under 1 year of age compared to other populations and resistance levels differed among pathotypes. In summary, our findings revealed the detailed resistance characteristics of diarrheagenic E. coli strains isolated from human sporadic diarrhea cases in China, offering valuable insights that can inform clinical antibiotic treatment strategies and priorities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF